An explanation for failure to predict cyclosporine area under the curve using a limited sampling strategy: A beginner's second note

Pharmacological Research

Volumn 35, Issue 6, 1997, Pages 547-552

  Wu, Guang ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Area under a blood drug concentration time curve; Correlation coefficient; Fourier series; Limited sampling strategy; Linear component; Non linear component

Indexed keywords

CYCLOSPORIN;

AREA UNDER THE CURVE; ARTICLE; CALCULATION; CORRELATION FUNCTION; DRUG BLOOD LEVEL; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SAMPLING; STEADY STATE;

EID: 0031172024     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0187     Document Type: Article

References (30)

1. 1. Cantarovich F, Bizollon C, Cantarovich D, Lefrançois N, Dubernard JM, Traeger J. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy. Transplantation 1988; 45: 389-94.
2. 2. Johnston A, Sketris I, Marsden JT, Galustian CG, Fashola T, Taube D, Pepper J, Holt DW. A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 1990; 22: 1345-6.
3. 3. Grevel J, Kahan BD. Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy. Clin Chem 1991; 37: 1905-8.
4. 4. Meyer M, Bennet W, Udeajan J, Munar M. Evaluation of efficacy of area under the curve (AUC) cyclosporine (CSA) monitoring [abstract]. J Am Soc Nephrol 1991; 2: 808.
5. 5. Ratain MJ, Vogelzang NJ. Limited sampling model for vinblastine pharmacokinetics. Cancer Treat Rep 1987; 71: 935-9.
6. 6. Ratain MJ, Staubus AE, Schilisky RL, Malspeis L. Limited sampling models for amonafide (NSC 308847) pharmacokinetics. Cancer Res 1988; 48: 4127-30.
7. 7. Ackland SP, Choi KE, Ratain MJ, Egorin MJ, Williams SF, Sinkule JA, Bitran JD. Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamide. J Clin Oncol 1988; 6: 1192-6.
8. 8. Egorin MJ, Forrest A, Belani CP, Ratain MJ, Abrams JS, Van Echo DA. A limited sampling strategy for cyclophosphamide pharmacokinetics. Cancer Res 1989; 49: 3129-33.
9. 9. Ratain MJ, Robert J, van der Vijgh WJF. Limited sampling models for doxorubicin pharmacokinetics. J Clin Oncol 1991; 9: 871-6.
10. 10. Sørensen BT, Strömgren AS, Jakobsen P, Jakobsen A. A limited sampling method for estimation of the carboplatin area under the curve. Cancer Chemother Pharmacol 1993; 31: 324-7.
11. 11. Strömgren AS, Sørensen BT, Jakobsen P, Jakobsen A. A Limited sampling method for estimation of the etoposide area under the curve. Cancer Chemother Pharmacol 1993; 32: 226-30.
12. 12. Eksborg S, Albertioni F, Beck O, Peterson C, Seideman P. Methotrexate in rheumatoid arthritis - a limited sampling strategy for estimation of the area under the plasma concentration versus time curve. Ther Drug Monit 1994; 16: 560-3.
13. 13. Gaspari F, Ruggenenti P, Torre L, Bertocchi C, Remuzzi G, Perico N. Failure to predict cyclosporine area under the curve using a limited sampling strategy. Kidney Int 1993; 44: 436-9.
14. 14. Wu G. Calculating predictive perfromance: a user's note. Pharmacol Res 1995; 31: 393-9.
15. 15. Wu G, Baraldo M, Furlanut M. Calculating percentage prediction error: a user's note. Pharmacol Res 1995; 32: 241-8.
16. 16. Deming SN, Morgan SL. The use of linear models and matrix least squares in clinical chemistry. Clin Chem 1979; 25: 840-55.
17. 17. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concept and applications. Stockholm: Swedish Pharmaceytical Press, 1994: 38-39.
18. 18. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503-12.
19. 19. Redondo FL. 'G'. Test and Evaluation of Assay Linearity. Clin Chem 1990; 36: 1384.
20. 20. Draper NR, Smith H. Aplies Regression Analysis. 2nd ed. New York: John Wiley, 1981: 46.
21. 21. Notari RE. Biopharmaceutics and Clinical Pharmacokinetics. New York: Marcel Dekker, 1987: 248.
22. 22. Minaja C. Argomenti di Matematica per Ingegneria. Padova: Edizioni Libreria Progetto, 1987: 1-23.
23. 23. Brasca L. Tavole Matematiche. 2nd ed. Milano: Ghisetti e Corvi Editori, 1980: 510.
24. 24. Awni WM, Heim-Duthoy KL, Kasiske BL. Therapeutic monitoring of cyclosporine by using pharmacokinetic studies. Clin Chem 1991; 37: 1891-2.
25. 25. Notari RE. Biopharmaceutics and Clinical Pharmacokinetics. New York: Marcel Dekker, 1987: 242.
26. 26. Peusner L. Ph.D. Thesis: 'The Principles of Network Thermodynamics.' Massachusetts: Harvard University, 1970.
27. 27. Wu G. Ph.D. Thesis: 'Modelling of Pharmacokinetic Process using Theory of Electrical Circuit.' Russian State Medical University, Moscow, 1992 (in Russian).
28. 28. Thakker KM. Pharmacokinetic-pharmacodynamic modelling and simulation using the electrical circuit simulation programme SPICE2. Biopharm Drug Dispos 1984; 5: 315-33.
29. 29. Oken DE, Thomas SR, Mikulecky DC. A network thermodynamic model of glomerular dynamics: application in the rat. Kidney Int 1981; 19: 359-73.
30. 30. Wu G. Fit fluctuating blood drug concentration: a beginner's first note. Pharmacol Res 1996; 33: 379-83.